AGENSYS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 56199
 
  
 
C07K PEPTIDES 5482
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 37169
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2772
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 13154
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1386
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7118
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS246
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0037,657 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO FLT3 PROTEINSMar 09, 16Feb 08, 18[A61K, C07K]
2017/0190,735 DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDESMay 27, 15Jul 06, 17[A61K, C07K]
2016/0347,855 PSCA: PROSTATE STEM CELL ANTIGEN AND USES THEREOFJun 13, 16Dec 01, 16[A61K, G01N, C07K]
2016/0256,563 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 161P2F10B PROTEINSMar 15, 16Sep 08, 16[A61K, C07K]
2009/0068,098 ANTIBODIES AND RELATED MOLECULES THAT BIND TO 58P1D12 PROTEINSAug 20, 08Mar 12, 09[A61K, C07H, C12Q, C12N, A01K, G01N, A61P, C40B, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9617346 Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsJan 23, 15Apr 11, 17[C07H, A61K, G01N, C07K]
9308278 Antibody drug conjugates (ADC) that bind to 161P2F10B proteinsDec 13, 13Apr 12, 16[A61K, C07K]
9029516 Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAug 31, 11May 12, 15[A61K, C12N, A01K, G01N, C07K]
9023605 Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAug 12, 11May 05, 15[A61K, G01N, C07K]
8968742 Antibody drug conjugates (ADC) that bind to 158P1D7 proteinsAug 23, 13Mar 03, 15[A61K, C07K]
8951744 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancersOct 26, 12Feb 10, 15[A61K, C12Q, G01N, C07K]
8945570 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancersOct 26, 12Feb 03, 15[A61K, A01N, A61B, C07K]
8853364 Prostate stem cell antigen (PSCA) variants and subsequences thereofSep 17, 09Oct 07, 14[A61K, C12P, G01N, C07K]
8846043 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerOct 21, 13Sep 30, 14[A61K]
8779111 Antibodies to tumor associated proteinsSep 14, 12Jul 15, 14[C07H, A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0176,977 NOVEL ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCERAbandonedSep 29, 14Jun 23, 16[C07K]
2016/0090,411 NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERSAbandonedFeb 02, 15Mar 31, 16[A61K, C07K]
2015/0218,220 AMATOXIN DERIVATIVES AND CELL-PERMEABLE CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASEAbandonedSep 12, 13Aug 06, 15[C07K]
2014/0364,591 PSCA: PROSTATE STEM CELL ANTIGEN AND USES THEREOFAbandonedJun 05, 14Dec 11, 14[C07K]
8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancerExpiredMar 18, 11Feb 11, 14[G01N]
2013/0267,024 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 282P1G3 USEFUL IN TREATMENT AND DETECTION OF CANCERAbandonedJun 07, 13Oct 10, 13[C12N]
8524872 Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancerExpiredMay 25, 12Sep 03, 13[C07K]
8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancerExpiredMar 08, 11Jul 30, 13[C07K]
2013/0190,248 SUBSTITUTED PEPTIDE ANALOGSAbandonedJul 24, 12Jul 25, 13[C07K]
2013/0177,569 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 202P5A5 USEFUL IN TREATMENT AND DETECTION OF CANCERAbandonedJan 24, 13Jul 11, 13[C07K]
8460881 Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancerExpiredMar 16, 09Jun 11, 13[G01N]
2013/0136,756 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 24P4C12 PROTEINSAbandonedNov 08, 12May 30, 13[A61K, C07K]
8426571 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancerExpiredFeb 04, 11Apr 23, 13[C07H, C12P, C12N]
2013/0041,138 ANTIBODIES THAT BIND TO PSCA PROTEINS FOR DIAGNOSIS OF CANCERAbandonedSep 28, 12Feb 14, 13[C07K]
2012/0202,208 NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 193P1E1B USEFUL IN TREATMENT AND DETECTION OF CANCERAbandonedApr 18, 12Aug 09, 12[C12Q, G01N]
8236510 Protein showing enhanced expression in cancer cellsExpiredJul 23, 10Aug 07, 12[G01N]
8212017 Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancerExpiredOct 06, 10Jul 03, 12[C07H, C12N]
8188228 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancerExpiredApr 20, 10May 29, 12[C07K]
8173132 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancerExpiredJan 21, 09May 08, 12[A61K]
8173381 Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancerExpiredJan 23, 09May 08, 12[G01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.